Abstract A dysfunctioning of Ca 2+ pump ATPase in the sarcoplasmic reticulum in vascular smooth muscle has been proposed as a contributing factor for the development of genetic hypertension. In this study, we determined whether in vitro inhibition of the sarcoplasmic reticulum Ca 2+ pump in vascular smooth muscle tissues and cultured cells isolated from aortas of spontaneously hypertensive rats (SHR) and WistarKyoto (WKY) rats would elicit the known alterations of contractile function and cell growth. We found the following common vascular effects of thapsigargin and cyclopiazonic acid, which are known to be selective inhibitors of sarcoplasmic reticulum Ca 2+ -ATPase in a number of tissues including smooth muscle: (1) 
I n genetic hypertension, functional defects in Ca

2+
handling by vascular smooth muscle cells have been proposed to be an etiologicalry important factor and may represent a major manifestation of a more generalized membrane defect. 1 -2 This defect may influence not only the contractile function of vascular smooth muscle in the regulation of blood flow and pressure but also vascular structural changes associated with the development of hypertension. Although an elevated cytosolic Ca 2+ concentration ([Ca 2+ ]i) has provided a logical explanation for a number of contractile abnormalities observed in the vascular muscle of spontaneously hypertensive rats (SHR), unequivocal demonstration of the elevation of [Ca 2+ ], in vascular smooth muscle cells and the proposed Ca mobilization pathways by which the [Ca 2+ ji becomes elevated have been matters of continuing dispute. 3 -6 Functionally, vascular muscle strips have been found to be more sensitive to the stimuli that affect Ca 2+ mobilization at the level of either the plasma membrane or sarcoplasmic reticulum (SR). 7 - 8 Coincidentally, cultured aortic and mesenteric smooth muscle cells tended to grow faster than Wistar-Kyoto (WKY) rat cells under normal cultured conditions. 39 Aortic smooth muscle cells from SHR showed an age-dependent change in the basal level of intracellular Ca from SHR compared with WKY rats 10 and also in the aortic smooth muscle cells from an experimental model (aortic coarctation) of hypertension. 6 It is therefore possible that there could be a connection between altered Ca 2+ metabolism and increased vascular smooth muscle proliferation. Previous studies have shown that in a smooth muscle cell line cloned from hamster vas deferens, a highly SR-selective Ca 2+ pump inhibitor, thapsigargin, 1113 was found to inhibit DNA synthesis, protein synthesis, and Ca 2+ -ATPase activities. 14 Inhibition of Ca 2+ sequestration by SR, presumably leading to elevated [Ca 2+ ] i; has been shown to cause an elevation of vascular tone in isolated strip preparations and cell shortening in enzymatically dispersed vascular smooth muscle cells, 12 which appear to mimic the contractile dysfunction observed in preparations from SHR compared with those from WKY rats. 15 Therefore, the primary purpose of this work was to study the effect of two putative SR-selective Ca 2+ pump inhibitors, thapsigargin and cyclopiazonic acid (CPA), on the attachment and growth of aortic smooth muscle cells isolated from SHR and WKY rats. Thapsigargin is originally derived from plant extracts, 11 and CPA is a toxin derived from fungi. They are structurally unrelated, but both are potent inhibitors of SR Ca 2+ pump. 1116 The effects of CPA on the contractility of rat tail artery were also studied and compared with previously reported effects of thapsigargin and CPA on other rat vascular tissues. 
Methods Animals
Male adult Wistar rats (325 to 400 g) were purchased from Charles River Canada, St Constant, Quebec. SHR and norby guest on July 10, 2017 http://hyper.ahajournals.org/ Downloaded from motensive WKY rats were obtained from the rat colonies maintained at McMaster University. These rats originated from the Charles River strains 10 to 18 years ago." Rats were kept and used following government guidelines for the use of experimental animals.
Contractility Studies
Wistar rats were killed by stunning and decapitation. The tail arteries were promptly removed and placed in Krebs' physiological solution at pH 7.4 containing (nunol/L) NaCl, 119; KCI, 5; CaCl 2> 2.5; MgCl 2 , 2; NaHCO 3 , 25; NaH 2 PO 4 , 1; and glucose, 11. Surrounding connective tissues were removed under a dissecting microscope, and vascular tissues were cut into helical strips of approximately 1.5 to 2 mm wide and 30 to 35 mm long. The vascular strips were mounted on a 3-mL organ bath connected to a force transducer (Grass FT03C) and a pen recorder. The organ baths and Krebs' solution were bubbled continuously with 95% O 2 and 5% CO 2 and warmed to 37°C. The solutions in the baths were changed every 20 to 30 minutes. Vascular strips were equilibrated for 20 minutes before the arteries were stretched to approximately 1 g and then were allowed to equilibrate further for at least 90 minutes. Pilot experiments have shown that these helical strips lose their endothelium-mediated responses, based on a lack of acetylcholine (10"* mol/L)-induced relaxation in strips precontracted with phenylephrine (10~6 mol/L). Before data collection, stimulation of the arteries with KCI (60 mmol/L) was repeated every 15 to 20 minutes for two to three times or until a reproducible contractile response was obtained. For Ca 2+ -free Krebs', Ca 2+ was omitted and EGTA (5 to 7.5xl0" 5 mol/L) was added. For assessment of the status of agonistsensitive intracellular Ca 2+ stores, the contractile response to 10" 3 mol/L phenylephrine was obtained and maintained until the contraction had returned to or close to its original baseline. After washout of the agonist, the aortic strips were exposed to 2.5 mmol/L Ca 2+ in the presence of 60 mmol/L KCI to recharge the intracellular Ca 2+ stores. The effectiveness of the Ca 2+ repletion was evaluated by the magnitude of the subsequent response to 10"' mol/L phenylephrine in Ca 2+ -free medium. Similarly, 50 mmol/L caffeine was used in the above protocol in lieu of phenylephrine for assessment of the status of Ca 2+ -induced Ca 2+ release stores.
Aortic Muscle Cell Culture Studies
Using the explant method, we obtained cultured smooth muscle cells from the thoracic aortas of SHR (systolic blood pressure, 160 to 180 mm Hg) and WKY rats (systolic blood pressure, 110 to 130 mm Hg) at the age of 10 to 12 weeks. 19 Passages of smooth muscle cells from these primary cultures were stored frozen in liquid nitrogen. Cells derived from each rat were propagated separately to compare differences between cells from different animals. For each experiment, cells from SHR and WKY rats in passages 6 to 7 were cultured under identical conditions with Dulbecco's modified Eagle medium (DMEM) with 10% fetal calf serum and 1% antibiotic-antimycotic solution. At confluency, SHR and WKY cells were synchronized with serum-poor medium (0.5% fetal calf serum in DMEM) for 48 hours. Smooth muscle cells were then trypsinized and seeded into multiwell (24) plates in DMEM with 10% fetal calf serum. The cell numbers were determined using a Coulter Counter with a 100 -/im orifice. Dimethyl sulfoxide (DMSO) was used as solvent for thapsigargin and CPA, so equivolume DMSO was also included as a separate control in the cell attachment and proliferation studies.
Drugs and Chemicals
All organic chemicals were purchased from Sigma Chemical Co, St Louis, Mo, and GIBCO, Grand Island, NY; all inorganic chemicals were obtained from Fischer, Toronto, Ontario, Canada, and BioRad, Mississauga, Ontario, Canada. Thapsigargin (Sigma) and CPA (Calbiochem, San Diego, Calif) were dissolved in DMSO and added to the bath media in volumes that did not exceed 30 /iL All other drugs were dissolved in deionized and double-distilled water.
Results
Effect of Cyclopiazonic Acid on Vascular Contractility
When increasing concentrations of CPA up to 10~4 mol/L were added cumulatively to vascular strips in normal Krebs' solution containing 2.5 mmol/L Ca 2+ , only a small, variable, and transient contraction was observed shortly after the addition of CPA at concentrations greater than 10" 5 mol/L in about one third of the vascular strip preparations. CPA had little effect on the basal tension of rat tail artery. The most prominent changes were an augmentation of the magnitude of KCl-induced contraction and an attenuation of the rate of relaxation in phenylephrine-induced contraction in the presence of CPA (Table) . These effects of CPA were readily reversible.
It is generally accepted that contraction via activation of a r adrenergic receptor uses both extracellular and intracellular Ca 2+ . However, in Ca 2+ -free medium, the contraction elicited by a,-adrenergic receptor agonist is transient, and the intracellular Ca 2+ store is readily depleted on repeated agonist stimulation. On washout of the agonist, reintroduction of extracellular Ca 2+ is known to keep the muscle strip quiescent despite a net increase in Ca 2+ influx, thus suggesting an effective refilling of the empty stores in the superficial SR underneath the plasmalemma. If the empty agonistsensitive store is refilled, a subsequent application of the agonist in Ca 2+ -free medium will again elicit a compa- tgo Indicates time required to allow 50% relaxation after washout; and to, time required for a full relaxation (returning to the basal tension). Values are mean±SD. Vascular preparations were challenged with KCI or phenylephrine In the absence of cyclopiazonic add (CPA). After washout of agonist and after responses fully relaxed to basal tension, CPA was added 15 minutes before reappllcatlon of agonists. Maximal contractile responses to KCI and phenylephrine were 0.85+0.06 and 1.59±0.14 g (n=7), respectively. After CPA treatment, the above maximal response to KCI was augmented to 1.30±0.17g (n=7) and that to phenylephrlne was not altered (1. 58±0.13 g, n=5) . After CPA washout, corresponding responses to KCI and phenylephrlne returned to control level: 0.84±0.10 (n=7) and 1.49±0.17 g (n-5), respectively. *Significantiy different from control. rable transient response. On the other hand, if the refilling process is inhibited, Ca 2+ entering the cells will be used to cause contraction only. Fig 1 shows the effects of CPA in rat tail artery when 10~5 mol/L phenyiephrine (or 5 x 10" 2 mol/L caffeine) was used to deplete the Ca 2+ stores. Two major differences were observed between the responses of control and CPAtreated vascular strips. First, reintroduction of Ca 2+ frequently resulted in a biphasic contraction in CPAtreated strips: a bigger transient response followed by a smaller but sustained response. In some strips, only the initial transient response was observed. In all cases, these contractile responses on readmission of Ca 2+ were largely prevented by 10~6 mol/L nifedipine. However, reintroduction of Ca 2+ had no effect in the control strips. Second, the subsequent application of the same agonist restored most of the transient contraction in Ca 2+ -free medium after reintroduction of Ca 2+ (>80% compared with that in the first application of agonist), but such responses were eliminated in the presence of CPA. Furthermore, nifedipine appeared to inhibit the refilling of the internal Ca 2+ stores necessary for the subsequent release of Ca 2+ by phenyiephrine.
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Effect of Thapsigargin and Cyclopiazonic Acid on Cell Attachment and Growth
Although the same seeding density of the aortic muscle cells was used in the study of cell growth, a change in cell attachment efficiency could lead to an artifact that mimics a change in cell growth as measured by cell count. Therefore, both cell attachment and cell growth were examined in SHR and WKY aortic cells. The attachment efficiency of smooth muscle cells 24 hours after seeding decreased from approximately 80% to 60% as the concentration of thapsigargin increased from 10~8 to 10" 7 mol/L (mean±SEM, from 78.00±4.14% to 58.00± 12.87% in SHR cells, n=4; from 79.50±7.96% to 65.00± 11.26% in WKY cells, n=4). The effect of CPA on cell attachment was relatively small as the concentration of CPA was increased from 5x10"* to 15x10"* mol/L in the culture medium (from 75.75±6.04% to 69.00±9.80% in SHR cells, n=4; from 77.00± 10.79% to 70.25±12.81% in WKY cells, n=4). DMSO at 0.5% was without any significant effect on the cell attachment. The difference due to different concentrations of thapsigargin and CPA compared with control (DMSO) was significant only for the high concentration of thapsigargin (10~7 mol/L) in both SHR and WKY cells (Ps.01). Furthermore, there was no difference between SHR and WKY cells in cell attachment under the above conditions by analysis of variance.
Results on cell growth studies indicated that thapsigargin and CPA inhibited the proliferation of both SHR and WKY aortic smooth muscle cells compared with control (0.5% DMSO, Figs 2 and 3, respectively) . In either case, the inhibitory effect on cell growth was more prominent in SHR than WKY cells. With the SHR cells, both thapsigargin and CPA significantly inhibited cell growth at various days after plating (P<.001 for thapsigargin and / Days in culture was observed only with thapsigargin at days 8 and 10 (P<.05) in relation to control (DMSO). The inhibitory effect of thapsigargin was much more potent than that of CPA. A similar inhibitory effect of 15xlO" 6 mol/L CPA could be effectively achieved by 10" 8 mol/L thapsigargin. Furthermore, DMSO at 0.5% also significantly inhibited cell growth in SHR and WKY groups, and this effect again was more potent in SHR than WKY cells. Thus, it appears that thapsigargin and CPA affected the proliferation of rat aortic cells from SHR and WKY rats in culture differentially, but this effect was not due to their effect on the attachment of the cells to the substrate.
Discussion
In this work we have clearly demonstrated that CPA caused functional impairment in the contractile properties of rat tail artery. Although we did not measure directly the cytosolic Ca 2+ , the mechanism of action of CPA on rat tail artery, like that on rat aorta, 17 is consistent with its inhibitory effects on the SR Ca 2+ pump. A major difference between the results obtained in this work and in our previous studies using aorta may reside in the dynamic nature of the responses on Ca 2+ reintroduction in the presence of CPA. In rat aorta, the responses were more sustained than those obtained in rat tail artery. This may be interpreted as the difference in the efficiency of the plasma membrane Ca 2+ pump in the removal of Ca 2+ from the cytosol. Unlike rat aorta, in which SR may play a more prominent role as an intracellular Ca 2+ sink, in smaller arteries such as rat tail artery, the plasma membrane function may be relatively more prominent such that the accumulated cytosolic Ca 2+ in the presence of CPA may be more effectively removed via extrusion across the plasma membrane. 13 It is therefore possible that quantitative or qualitative changes in contractile responses may be present in different vasculatures, or under different experimental conditions, in which the relative contribution of plasmalemmal or SR activities in Ca 2+ handling may be differentially altered in hypertension. The present findings on vascular smooth muscle indeed underscore some functional alterations of vascular smooth muscle reported in SHR. These alterations include (1) reduced rate of relaxation to KC1-and phenylephrineinduced contraction in vascular smooth muscle as well as in nonvascular smooth muscle, 2+ to vascular muscle preparation previously depleted of internal Ca 2+ by phenylephrine in Ca 2+ -free medium. 15 Therefore, the fact that the effects of CPA on the contractile function of vascular smooth muscle mimic the contractile abnormalities of vascular muscle in hypertension lends further support to the hypothesis that impaired SR Ca 2+ pump may be an important factor in the pathogenesis of hypertension.
Although thapsigargin is generally more potent than CPA in inhibiting SR-selective Ca 2+ pump and cellular proliferation, the effect of CPA is considerably rapid 17 (<15 minutes as opposed to 1 to 2 hours for thapsigargin 12 -13 ) and readily reversible (thapsigargin is practically irreversible, and its possible long-term side effects have not been assessed). Our finding that smooth muscle cells from SHR were more sensitive to growth inhibition by thapsigargin and CPA than those from WKY rats is indicative of the difference in Ca 2+ handling between the cells from these two strains. This could be one of the contributing factors in the difference in vascular smooth muscle cell growth rate observed between SHR and WKY rats.
